Martinez Y, Ferreira F, Musumeci M
World J Microbiol Biotechnol. 2022; 38(11):204.
PMID: 36002753
DOI: 10.1007/s11274-022-03391-5.
Shah L, Nadeem M, Khan J, Zeyadi M, Zamzami M, Mohammed K
RSC Adv. 2022; 9(8):4258-4267.
PMID: 35520186
PMC: 9060542.
DOI: 10.1039/c8ra04740e.
Correa-Ferreira M, Pires A, Resendes Barbosa I, Echevarria A, Pedrassoli G, Winnischofer S
Mol Cell Biochem. 2022; 477(8):2033-2045.
PMID: 35420333
DOI: 10.1007/s11010-022-04423-2.
Ferreira F, Herrmann-Andrade A, Binolfi A, Calabrese C, Mac Cormack W, Musumeci M
Appl Biochem Biotechnol. 2021; 193(10):3121-3138.
PMID: 34085170
DOI: 10.1007/s12010-021-03596-8.
Malgapo M, Safadi J, Linder M
J Biol Chem. 2020; 296:100106.
PMID: 33219126
PMC: 7949124.
DOI: 10.1074/jbc.RA120.015701.
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker.
Duvall B, Zimmermann S, Gao R, Thomas A, Kalcic F, Veeravalli V
Bioorg Med Chem. 2020; 28(20):115698.
PMID: 33069080
PMC: 9115729.
DOI: 10.1016/j.bmc.2020.115698.
Regulation of hepatic glutamine metabolism by miR-122.
Sengupta D, Cassel T, Teng K, Aljuhani M, Chowdhary V, Hu P
Mol Metab. 2020; 34:174-186.
PMID: 32180557
PMC: 7044666.
DOI: 10.1016/j.molmet.2020.01.003.
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Menezes Dos Reis L, Adamoski D, Oliveira Souza R, Rodrigues Ascencao C, Sousa de Oliveira K, Correa-da-Silva F
J Biol Chem. 2019; 294(24):9342-9357.
PMID: 31040181
PMC: 6579458.
DOI: 10.1074/jbc.RA119.008180.
Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration.
Li Y, Peer J, Zhao R, Xu Y, Wu B, Wang Y
Transl Neurodegener. 2017; 6:10.
PMID: 28439409
PMC: 5399437.
DOI: 10.1186/s40035-017-0080-x.
Structural basis for exploring the allosteric inhibition of human kidney type glutaminase.
Ramachandran S, Pan C, Zimmermann S, Duvall B, Tsukamoto T, Low B
Oncotarget. 2016; 7(36):57943-57954.
PMID: 27462863
PMC: 5295402.
DOI: 10.18632/oncotarget.10791.
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
Lukey M, Greene K, Erickson J, Wilson K, Cerione R
Nat Commun. 2016; 7:11321.
PMID: 27089238
PMC: 4837472.
DOI: 10.1038/ncomms11321.
Sulforaphane Prevents Methylmercury-Induced Oxidative Damage and Excitotoxicity Through Activation of the Nrf2-ARE Pathway.
Feng S, Xu Z, Wang F, Yang T, Liu W, Deng Y
Mol Neurobiol. 2016; 54(1):375-391.
PMID: 26742517
DOI: 10.1007/s12035-015-9643-y.
Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer.
Xie C, Jin J, Bao X, Zhan W, Han T, Gan M
Oncotarget. 2015; 7(1):610-21.
PMID: 26575584
PMC: 4808021.
DOI: 10.18632/oncotarget.6311.
Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells.
Stalnecker C, Ulrich S, Li Y, Ramachandran S, McBrayer M, DeBerardinis R
Proc Natl Acad Sci U S A. 2014; 112(2):394-9.
PMID: 25548170
PMC: 4299208.
DOI: 10.1073/pnas.1414056112.
Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase.
McDonald C, Acheff E, Kennedy R, Taylor L, Curthoys N
Neurochem Int. 2014; 88:10-4.
PMID: 25510640
PMC: 4465886.
DOI: 10.1016/j.neuint.2014.12.003.
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
Lee Y, Yang C, Chang H, Hsu H, Chen I, Chang H
Oncotarget. 2014; 5(15):6087-101.
PMID: 25026281
PMC: 4171615.
DOI: 10.18632/oncotarget.2173.
A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor.
Elhammali A, Ippolito J, Collins L, Crowley J, Marasa J, Piwnica-Worms D
Cancer Discov. 2014; 4(7):828-39.
PMID: 24740997
PMC: 4197823.
DOI: 10.1158/2159-8290.CD-13-0572.
Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).
Thangavelu K, Chong Q, Low B, Sivaraman J
Sci Rep. 2014; 4:3827.
PMID: 24451979
PMC: 4929687.
DOI: 10.1038/srep03827.
Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.
Mehta R, Verma S, Pati R, Sengupta M, Khatua B, Jena R
J Biol Chem. 2013; 289(6):3555-70.
PMID: 24297177
PMC: 3916557.
DOI: 10.1074/jbc.M113.486530.
Small angle X-ray scattering studies of mitochondrial glutaminase C reveal extended flexible regions, and link oligomeric state with enzyme activity.
Moller M, Nielsen S, Ramachandran S, Li Y, Li Y, Tria G
PLoS One. 2013; 8(9):e74783.
PMID: 24098668
PMC: 3787022.
DOI: 10.1371/journal.pone.0074783.